169 related articles for article (PubMed ID: 35355509)
1. The Prognostic Value of Lysine Acetylation Regulators in Hepatocellular Carcinoma.
Sun L; Zhang J; Wen K; Huang S; Li D; Xu Y; Wu J
Front Mol Biosci; 2022; 9():840412. PubMed ID: 35355509
[No Abstract] [Full Text] [Related]
2. Systematic and Multi-Omics Prognostic Analysis of Lysine Acetylation Regulators in Glioma.
Tu Z; Wu L; Luo H; Li J; Lv S; Ye M; Liu F; Tao C; Zhu X; Huang K
Front Mol Biosci; 2021; 8():587516. PubMed ID: 33718432
[TBL] [Abstract][Full Text] [Related]
3. Profiles of Acetylation Regulation Genes Contribute to Malignant Progression and Have a Clinical Prognostic Impact on Liver Cancer.
Zhu W; Zhang X; Yu M; Zhang Y; Li S; Yu C
Dis Markers; 2022; 2022():1724301. PubMed ID: 36124029
[TBL] [Abstract][Full Text] [Related]
4. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.
Yan Z; He M; He L; Wei L; Zhang Y
Front Immunol; 2021; 12():723271. PubMed ID: 34925311
[TBL] [Abstract][Full Text] [Related]
5. Five metastasis-related mRNAs signature predicting the survival of patients with liver hepatocellular carcinoma.
Chen C; Liu YQ; Qiu SX; Li Y; Yu NJ; Liu K; Zhong LM
BMC Cancer; 2021 Jun; 21(1):693. PubMed ID: 34116652
[TBL] [Abstract][Full Text] [Related]
6. Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma.
Ni W; Bian S; Zhu M; Song Q; Zhang J; Xiao M; Zheng W
Front Oncol; 2021; 11():629327. PubMed ID: 33718205
[TBL] [Abstract][Full Text] [Related]
7. Co-amplification of genes in chromosome 8q24: a robust prognostic marker in hepatocellular carcinoma.
Zheng Y; Cheng Y; Zhang C; Fu S; He G; Cai L; Qiu L; Huang K; Chen Q; Xie W; Chen T; Huang M; Bai Y; Pan M
J Gastrointest Oncol; 2021 Jun; 12(3):1086-1100. PubMed ID: 34295559
[TBL] [Abstract][Full Text] [Related]
8. Identification of a Liver Progenitor Cell-Related Genes Signature Predicting Overall Survival for Hepatocellular Carcinoma.
Li X; Lin J; Pan Y; Cui P; Xia J
Technol Cancer Res Treat; 2021; 20():15330338211041425. PubMed ID: 34866477
[No Abstract] [Full Text] [Related]
9. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma.
Chen S; Zhao E
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631
[TBL] [Abstract][Full Text] [Related]
10. Identification, Verification and Pathway Enrichment Analysis of Prognosis-Related Immune Genes in Patients With Hepatocellular Carcinoma.
Zhu Z; Song M; Li W; Li M; Chen S; Chen B
Front Oncol; 2021; 11():695001. PubMed ID: 34616672
[TBL] [Abstract][Full Text] [Related]
11. A Novel RNA Binding Protein-Related Prognostic Signature for Hepatocellular Carcinoma.
Huang Y; Chen S; Qin W; Wang Y; Li L; Li Q; Yuan X
Front Oncol; 2020; 10():580513. PubMed ID: 33251144
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L
J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766
[TBL] [Abstract][Full Text] [Related]
13. Identification and Validation of Pyroptosis-Related Gene Signature to Predict Prognosis and Reveal Immune Infiltration in Hepatocellular Carcinoma.
Fu XW; Song CQ
Front Cell Dev Biol; 2021; 9():748039. PubMed ID: 34820376
[No Abstract] [Full Text] [Related]
14. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y
Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356
[TBL] [Abstract][Full Text] [Related]
15. Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma.
Xu Q; Xu H; Deng R; Li N; Mu R; Qi Z; Shen Y; Wang Z; Wen J; Zhao J; Weng D; Huang W
Cancer Cell Int; 2021 Apr; 21(1):190. PubMed ID: 33794886
[TBL] [Abstract][Full Text] [Related]
16. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q
Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic value of m5C regulatory genes in hepatocellular carcinoma.
Yang X; Yang F; Lan L; Wen N; Li H; Sun X
Front Genet; 2022; 13():972043. PubMed ID: 36105093
[No Abstract] [Full Text] [Related]
18. Bioinformatics analysis and experimental verification of the prognostic and biological significance mediated by fatty acid metabolism related genes for hepatocellular carcinoma.
Zhu XR; Zhu JQ; Chen YF; Liu YY; Lu JJ; Sun J; Peng SQ; Chen MB; Du YP
Front Oncol; 2022; 12():972744. PubMed ID: 35982956
[TBL] [Abstract][Full Text] [Related]
19. A Prognostic Model of 15 Immune-Related Gene Pairs Associated With Tumor Mutation Burden for Hepatocellular Carcinoma.
Huo J; Wu L; Zang Y
Front Mol Biosci; 2020; 7():581354. PubMed ID: 33282911
[TBL] [Abstract][Full Text] [Related]
20. The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinoma.
Fang Q; Chen H
Mol Med; 2020 Jun; 26(1):60. PubMed ID: 32552682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
